Fresenius Kabi Oncology Limited Valid
CEP Certificates (EDQM COS List)

Fresenius Kabi Oncology Limited Valid

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical India
  • Total Records 14
  • Latest End Date -
  • Data Source EDQM
  • Last Updated 2026-04-20
All
17
View
Valid
14
View
Withdrawn
3
View
Company Overview

Company

Fresenius Kabi Oncology Limited Valid

Country

India

Email

Social Profiles

Company Snapshot

Fresenius Kabi Oncology Limited Valid

Echelon Institutional Area Plot No-11, Sector - 32 Gurgaon Pin code - 122001 Haryana

India

www.fresenius-kabi-oncology.com/company.html View on Map
CEP Records Timeline (14 records)
2026
20 Apr
Chemical Valid

Product

Cisplatin

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2025-204 - Rev 00

Substance No.

599

Issue Date

2026-04-20

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2025-204 - Rev 00
Substance No.: 599

2025
29 Sep
Chemical Valid

Product

Paclitaxel, Semi-synthetic process

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2008-181 - Rev 12

Substance No.

1794

Issue Date

2025-09-29

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2008-181 - Rev 12
Substance No.: 1794

2025
08 Sep
Chemical Valid

Product

Busulfan

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2010-374 - Rev 09

Substance No.

542

Issue Date

2025-09-08

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2010-374 - Rev 09
Substance No.: 542

2025
24 Jan
Chemical Valid

Product

Docetaxel trihydrate

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2011-189 - Rev 05

Substance No.

2449

Issue Date

2025-01-24

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2011-189 - Rev 05
Substance No.: 2449

2024
02 Dec
Chemical Valid

Product

Docetaxel

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2012-293 - Rev 03

Substance No.

2593

Issue Date

2024-12-02

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2012-293 - Rev 03
Substance No.: 2593

2024
04 Nov
Chemical Valid

Product

Gemcitabine hydrochloride

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2008-131 - Rev 05

Substance No.

2306

Issue Date

2024-11-04

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2008-131 - Rev 05
Substance No.: 2306

2024
26 Aug
Chemical Valid

Product

Carboplatin

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2001-282 - Rev 14

Substance No.

1081

Issue Date

2024-08-26

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2001-282 - Rev 14
Substance No.: 1081

2024
04 Jun
Chemical Valid

Product

Oxaliplatin

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2007-193 - Rev 06

Substance No.

2017

Issue Date

2024-06-04

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2007-193 - Rev 06
Substance No.: 2017

2024
22 Apr
Chemical Valid

Product

Irinotecan hydrochloride trihydrate

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2017-234 - Rev 03

Substance No.

2675

Issue Date

2024-04-22

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2017-234 - Rev 03
Substance No.: 2675

2023
06 Dec
Chemical Valid

Product

Gemcitabine hydrochloride, Alternate Process-2

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

CEP 2023-271 - Rev 00

Substance No.

2306

Issue Date

2023-12-06

End Date

-

Country

India

Identifiers

Certificate No.: CEP 2023-271 - Rev 00
Substance No.: 2306

2023
09 Jan
Chemical Valid

Product

Letrozole

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

R1-CEP 2007-338 - Rev 03

Substance No.

2334

Issue Date

2023-01-09

End Date

-

Country

India

Identifiers

Certificate No.: R1-CEP 2007-338 - Rev 03
Substance No.: 2334

2021
14 Sep
Chemical Valid

Product

Ropivacaine hydrochloride monohydrate, Alternate process

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

R0-CEP 2021-130 - Rev 00

Substance No.

2335

Issue Date

2021-09-14

End Date

-

Country

India

Identifiers

Certificate No.: R0-CEP 2021-130 - Rev 00
Substance No.: 2335

2021
20 May
Chemical Valid

Product

Bicalutamide

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

R1-CEP 2012-369 - Rev 00

Substance No.

2196

Issue Date

2021-05-20

End Date

-

Country

India

Identifiers

Certificate No.: R1-CEP 2012-369 - Rev 00
Substance No.: 2196

2019
08 Oct
Chemical Valid

Product

Gemcitabine hydrochloride, Alternate process

Substance

FRESENIUS KABI ONCOLOGY LIMITED Kalyani IN

Certificate No.

R1-CEP 2012-080 - Rev 01

Substance No.

2306

Issue Date

2019-10-08

End Date

-

Country

India

Identifiers

Certificate No.: R1-CEP 2012-080 - Rev 01
Substance No.: 2306

Related Databases
  • FDA Inspections
    10 View
  • EDQM CEP
    17 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Status Breakdown
14 total
  • Valid
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

India

Identifiers

Certificate No.: CEP 2025-204 - Rev 00
Substance No.: 599

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.